Phase 1 Biosimilar Study:
- Strict eligibility criteria.
- A limited pool of healthy volunteers.
- Recruitment during the holiday season.
These were just some of the challenges our team faced in a recent Phase 1 biosimilar study conducted across two continents.
🎯 Our approach was clear: act fast, stay coordinated, and monitor data in real time.
Key operational focus:
- Rapid and coordinated site activation
- High-volume screening supported by efficient scheduling
- Smooth enrollment with full participant retention
- Continuous medical oversight to ensure stable study conduct
- Real-time data monitoring enabling confident decisions
🏆 The outcome? Fast screening, strong retention, and reliable study delivery — even under challenging conditions.
🔎 Explore the full case study, which includes all performance metrics, to see how we support biosimilar sponsors with reliable early phase execution.
Because we care.
